- Home
- OBIO vs NNY Comparison
OBIO vs NNY Comparison
Compare OBIO & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- NNY
- Stock Information
- Founded
- OBIO 2017
- NNY 1987
- Country
- OBIO United States
- NNY United States
- Employees
- OBIO N/A
- NNY N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- NNY Investment Managers
- Sector
- OBIO Health Care
- NNY Finance
- Exchange
- OBIO Nasdaq
- NNY Nasdaq
- Market Cap
- OBIO 172.1M
- NNY 159.8M
- IPO Year
- OBIO N/A
- NNY N/A
- Fundamental
- Price
- OBIO $4.24
- NNY $8.40
- Analyst Decision
- OBIO Strong Buy
- NNY
- Analyst Count
- OBIO 4
- NNY 0
- Target Price
- OBIO $13.67
- NNY N/A
- AVG Volume (30 Days)
- OBIO 301.5K
- NNY 50.9K
- Earning Date
- OBIO 11-10-2025
- NNY 01-01-0001
- Dividend Yield
- OBIO N/A
- NNY 4.04%
- EPS Growth
- OBIO N/A
- NNY N/A
- EPS
- OBIO N/A
- NNY N/A
- Revenue
- OBIO $2,818,000.00
- NNY N/A
- Revenue This Year
- OBIO $31.43
- NNY N/A
- Revenue Next Year
- OBIO $10.87
- NNY N/A
- P/E Ratio
- OBIO N/A
- NNY N/A
- Revenue Growth
- OBIO 6.46
- NNY N/A
- 52 Week Low
- OBIO $2.20
- NNY $7.58
- 52 Week High
- OBIO $6.30
- NNY $8.87
- Technical
- Relative Strength Index (RSI)
- OBIO 63.87
- NNY 51.18
- Support Level
- OBIO $3.86
- NNY $8.40
- Resistance Level
- OBIO $4.02
- NNY $8.58
- Average True Range (ATR)
- OBIO 0.30
- NNY 0.13
- MACD
- OBIO 0.00
- NNY -0.01
- Stochastic Oscillator
- OBIO 89.22
- NNY 31.58
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About NNY Nuveen New York Municipal Value Fund
Nuveen New York Municipal Value Fund Inc. is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.